Pristimerin synergizes with gemcitabine through abrogating Chk1/53BP1-mediated DNA repair in pancreatic cancer cells
Zhuangzhuang Jiang(Yangzhou University), Tao Li(Yangzhou University), Yang Zhao(Nanjing University of Chinese Medicine), Yanqing Liu(Wenzhou University), Yang Zhao(École Polytechnique Fédérale de Lausanne)
Cited by 23
Related Papers
Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity
|Nature Immunology|2021|422
IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases
|Nature Biotechnology|2024|258
Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity
|Journal of Controlled Release|2015|254